Samsung’s United States headquarters of digital radiography and ultrasound, Boston Imaging, introduces the HERA W10 Elite1; the most advanced model of the HERA platform for Obstetrics and Gynecology. This revolutionary platform offers clinicians a suite of cutting-edge artificial intelligence (AI) tools and clinical applications to enhance their diagnostic capabilities. HERA W10 Elite1 is the go-to choice for medical professionals looking to take their practice to the next level.
The HERA W10 Elite is the perfect choice for those seeking an ergonomic-friendly design, as well as superior imaging capabilities. With its updated imaging technology, you can rest assured that you’re getting the most accurate diagnosis. Its design is crafted to provide you with the utmost comfort and confidence in your treatment.
The HERA W10 Elite is revolutionizing the field of women’s health, bringing advanced patient care capabilities to Obstetrics and Gynecology. With its sophisticated image processing and ergonomic design, it’s changing the landscape of care for women everywhere.
The HERA W10 Elite is revolutionizing diagnosis with its intuitive visualizations, precise analytics and fast operation. Clinicians are gaining greater insight and accuracy with the improved system, which has been upgraded in a number of ways from its predecessor. These enhancements include faster operation, more precise analytics and intuitive visualizations to provide a more effective and efficient diagnostic process.
MV-Flow™ offers an unprecedented insight into the dynamics of the body’s circulatory system, enabling users to observe the intensity of blood flow in both 2D and 3D. From microcirculation to slow-moving blood, this cutting-edge technology offers a comprehensive view of the circulatory system like never before.
The OLED3 screen on our latest device has been dramatically improved, with a 57% larger display area and realistic black color representation. This makes it perfect for capturing and displaying ultrasound images with incredible detail and accuracy.
The EV2-124 transducer is revolutionary in its ability to provide a detailed view of the fetal heart and brain as early as eight weeks into the pregnancy, all through a simple endovaginal procedure. This groundbreaking technology allows doctors and expectant parents to monitor the health of the growing baby with unprecedented accuracy.
The system is also equipped with cutting-edge AI features that make it truly stand out. These features include advanced natural language processing, deep learning capabilities, and enhanced decision-making algorithms, enabling it to make smarter decisions and providing users with more accurate results. With this advanced technology, users can enjoy a more efficient and effective experience.
HeartAssist™ is revolutionizing ultrasound imaging with its cutting-edge technology. It automatically classifies an ultrasound image into the specific measurement views needed for fetal heart diagnosis and provides accurate measurement results. This game-changing tool is making prenatal care easier and more efficient than ever before.
ViewAssist™ is revolutionizing the way ultrasound images are classified and annotated for easy measurement. With 16 new views added, it offers a seamless and automated process that makes the task of measuring ultrasound images much simpler and more efficient.
BiometryAssist™ revolutionizes fetal care with its revolutionary technology, allowing clinicians to effortlessly measure fetal growth parameters with a single click, while still ensuring exam consistency. This groundbreaking innovation is truly transforming the way obstetricians care for their expectant mothers and babies.
Samsung is proud to introduce its new HERA W10 Elite ultrasound system, designed to support the life-long healthcare of women. This cutting-edge technology will be on display at the Society for Maternal Fetal Medicine’s 43rd Annual Pregnancy Meeting from February 8 to 10 at booth #317. Don’t miss your chance to get up close and personal with this innovative new system, which promises to revolutionize women’s healthcare.